Oncogene-independent resistance in Philadelphia chromosome - positive (Ph+) acute lymphoblastic leukemia (ALL) is mediated by activation of AKT/mTOR pathway-Reference-Cited by-同舟云学术

Oncogene-independent resistance in Philadelphia chromosome - positive (Ph+) acute lymphoblastic leukemia (ALL) is mediated by activation of AKT/mTOR pathway

Published:2021-09 Issue:9 Volume:23 Page:1016-1027
ISSN:1476-5586
Container-title:Neoplasia
language:en
Short-container-title:Neoplasia

Author:

Mian Afsar Ali,Zafar Usva,Ahmed Syed Muhammad Areeb,Ottmann Oliver Gerhard,Lalani El-Nasir M A

Funder

Aga Khan University

Publisher

Elsevier BV

Subject

Cancer Research

Reference63 articles.

1. The biology of chronic myeloid leukemia;Faderl;N Engl J Med,1999

2. Letter: a new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining;Rowley;Nature,1973

3. The molecular biology of chronic myeloid leukemia;Deininger;Blood,2000

4. Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells;Druker;Nat Med,1996

5. Nilotinib is effective in imatinib-resistant or -intolerant patients with chronic myeloid leukemia in blastic phase;Giles;Leukemia,2012

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The potential role of RNA sequencing in diagnosing unexplained insensitivity to conventional chemotherapy in pediatric patients with B-cell acute lymphoblastic leukemia;BMC Medical Genomics;2024-05-29

2. The allosteric mechanism of mTOR activation can inform bitopic inhibitor optimization;Chemical Science;2024

3. Protein tyrosine kinase inhibitor resistance in malignant tumors: molecular mechanisms and future perspective;Signal Transduction and Targeted Therapy;2022-09-17